Log In
Print
BCIQ
Print
Print this Print this
 

FT301

  Manage Alerts
Collapse Summary General Information
Company Fate Therapeutics Inc.
DescriptionWingless-type MMTV integration site family member 7A (WNT7A) analog
Molecular Target Wingless-type MMTV integration site family member 7A (WNT7A)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular dystrophy
Indication DetailsTreat muscular dystrophy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today